@article{4d3cbcc24df6427d9cc34cae85fceab5,
title = "Consistent safety profile with up to 5 years of continuous treatment with guselkumab: Pooled analyses from the phase 3 VOYAGE 1 and VOYAGE 2 trials of patients with moderate-to-severe psoriasis",
author = "Andrew Blauvelt and Tsai, {Tsen Fang} and Langley, {Richard G.} and Megan Miller and Shen, {Yaung Kaung} and Yin You and Yang, {Ya Wen} and Papp, {Kim A.} and Luis Puig",
note = "Funding Information: Funding sources: These studies were funded by Janssen Research & Development, LLC, Spring House, Pennsylvania.Dr Blauvelt has served as a scientific advisor and/or clinical study investigator for AbbVie, Abcentra, Aligos, Almirall, Amgen, Arcutis, Arena, Aslan, Athenex, Boehringer Ingelheim, Bristol Myers Squibb, Dermavant, Eli Lilly and Company, Evommune, Forte, Galderma, Incyte, Janssen, Landos, LEO Pharma, Novartis, Pfizer, Rapt, Regeneron, Sanofi Genzyme, Sun Pharmaceutical, and UCB Pharma. Dr Tsai has served as a consultant for AbbVie, Boehringer Ingelheim, Bristol Myers Squibb, Celgene, Galderma, GlaxoSmithKline, Janssen, LEO Pharma, Lilly, Merck Sharpe & Dohme, Novartis, Pfizer, and UCB. Dr Langley has received honoraria as principal investigator, scientific advisory board member, and/or lecturer for AbbVie, Amgen, Boehringer Ingelheim, Celgene, Eli Lilly, Janssen, LEO Pharma, Merck, Novartis, Pfizer, Sun Pharmaceutical, and UCB Pharma. Drs Miller, Shen, and You are employees of Janssen Research & Development, LLC. Dr Yang is an employee of Immunology Global Medical Affairs, Janssen Pharmaceutical Companies of Johnson & Johnson (employees may own stock in Johnson & Johnson, of which Janssen is a subsidiary). Dr Papp has served as a consultant, scientific advisor, investigator, consultant, speaker, and/or medical officer for AbbVie, Akros, Amgen, Anacor, Arcutis, Astellas, Avillion, Bausch Health, Baxalta, Boehringer Ingelheim, Bristol Myers Squibb, Can-Fite Biopharma, Celgene, Coherus, Dermavant, Dermira, Dow Pharma, Eli Lilly, Evelo, Galapagos, Galderma, Genentech, Gilead, GlaxoSmithKline, Incyte, Janssen, Kyowa Hakko Kirin, LEO Pharma, Medimmune, Meiji Seika Pharma, Merck Sharpe & Dohme, Merck-Serono, Mitsubishi Pharma, Moberg Pharma, Novartis, Pfizer, PRCL Research, Regeneron, Roche, Sanofi-Aventis/Genzyme, Sun Pharma, Takeda, UCB Pharma, and Valeant. Dr Puig has received consultancy/speaker's honoraria from and/or participated in clinical trials sponsored by AbbVie, Almirall, Amgen, Baxalta, Biogen, Boehringer Ingelheim, Bristol Myers Squibb, Celgene, Fresenius-Kabi, Gebro, Janssen, JS BIOCAD, LEO Pharma, Lilly, Merck-Serono, MSD, Mylan, Novartis, Pfizer, Regeneron, Roche, Sandoz, Samsung-Bioepis, Sanofi, and UCB. Publisher Copyright: {\textcopyright} 2021 American Academy of Dermatology, Inc.",
year = "2022",
month = apr,
doi = "10.1016/j.jaad.2021.11.004",
language = "English",
volume = "86",
pages = "827--834",
journal = "Journal of the American Academy of Dermatology",
issn = "0190-9622",
publisher = "Mosby Inc.",
number = "4",
}
